109 related articles for article (PubMed ID: 38668351)
1. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic Activity of Rice Resistant-Starch Metabolites: A Mechanistic Network Pharmacology and In Vitro Approach.
Ren J; Dai J; Chen Y; Wang Z; Sha R; Mao J; Mao Y
Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668351
[TBL] [Abstract][Full Text] [Related]
3. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking.
Li H; Luo D; Wei R; Sun M; Zhang X; Deng H; Bian W; Wei H; Huang Y
Biomed Res Int; 2022; 2022():7978258. PubMed ID: 36452059
[TBL] [Abstract][Full Text] [Related]
5. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
6. In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids.
Hirano S; Masuda N; Oda H
J Lipid Res; 1981 Jul; 22(5):735-43. PubMed ID: 7288282
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification.
Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S
J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194
[TBL] [Abstract][Full Text] [Related]
8. Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets.
Su C; Mo J; Dong S; Liao Z; Zhang B; Zhu P
Cell Commun Signal; 2024 Jan; 22(1):71. PubMed ID: 38279122
[TBL] [Abstract][Full Text] [Related]
9. Statistical Characterization of Food-Derived α-Amylase Inhibitory Peptides: Computer Simulation and Partial Least Squares Regression Analysis.
Li W; Yang S; An J; Wang M; Li H; Liu X
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257308
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
[TBL] [Abstract][Full Text] [Related]
11. Identification of basement membrane markers in diabetic kidney disease and immune infiltration by using bioinformatics analysis and experimental verification.
Shi R; Zhao WM; Zhu L; Wang RF; Wang DG
IET Syst Biol; 2023 Dec; 17(6):316-326. PubMed ID: 37776100
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach.
Taherkhani A; Khodadadi P; Samie L; Azadian Z; Bayat Z
Int J Anal Chem; 2023; 2023():8899240. PubMed ID: 37090055
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes.
Ahmad E; Lim S; Lamptey R; Webb DR; Davies MJ
Lancet; 2022 Nov; 400(10365):1803-1820. PubMed ID: 36332637
[TBL] [Abstract][Full Text] [Related]
14. Research Progress on Hypoglycemic Mechanisms of Resistant Starch: A Review.
Liu J; Lu W; Liang Y; Wang L; Jin N; Zhao H; Fan B; Wang F
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296704
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
